Evolent Health Inc. (EVH)
8.51
-0.45 (-5.02%)
At close: Apr 21, 2025, 3:59 PM
Evolent Health Revenue Breakdown
| Period Ending | Dec 31, 2024 | Sep 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Evolent Health Services Segment Revenue | 1.29B | 621.4M | 639.65M | 556.05M | 511.01M | 469.14M | 427.69M | 100.98M | 107.33M | 92.34M | 106.86M |
| Evolent Health Services Segment Revenue Growth | +108.19% | -2.85% | +15.03% | +8.81% | +8.93% | +9.69% | +323.54% | -5.91% | +16.24% | -13.59% | n/a |
Revenue by Geography
| Period Ending | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 |
|---|---|---|---|
| Services Segment Revenue | 690.39M | 458.99M | 32.92M |
| Services Segment Revenue Growth | +50.41% | +1294.43% | n/a |
Operating Expense Breakdown
| Period Ending | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 47.7M | 67.06M | 67.22M | 68.78M | 81.43M | 96.57M | 90.39M | 89.73M | 82.86M | 68.52M | 58.95M | 58.93M | 66.92M | 51.29M | 42.7M | 58.59M | 86.45M | 77.08M | 68.66M | 78.36M | 83.6M | 93.61M | 103.02M | 112.59M | 81.69M | 76.56M | 75.83M | 72.28M | 55.2M | 45.83M | 51.09M | 53.55M | 57.59M | 38.4M | 32.76M | 32.09M | 32.37M | 29.83M | 13.08M | 28.45M |
| Selling, General, and Administrative Revenue Growth | -28.87% | -0.23% | -2.27% | -15.54% | -15.68% | +6.83% | +0.74% | +8.28% | +20.93% | +16.23% | +0.04% | -11.93% | +30.46% | +20.12% | -27.12% | -32.22% | +12.15% | +12.28% | -12.39% | -6.26% | -10.70% | -9.13% | -8.51% | +37.84% | +6.70% | +0.96% | +4.92% | +30.94% | +20.43% | -10.29% | -4.59% | -7.02% | +49.99% | +17.22% | +2.06% | -0.85% | +8.50% | +128.05% | -54.02% | n/a |
| Research and Development Revenue | n/a | n/a | 6.7M | 6.3M | 6.6M | 6.6M | 6.8M | 6.7M | 7.4M | 6.4M | 3.8M | 4.1M | 6.5M | 6.7M | 6.6M | 10.1M | 21.6M | 6.2M | 6M | 5.6M | 25M | 4.9M | 4.5M | 4.1M | 30.6M | n/a | 2.9M | 2.5M | 19.3M | 1.2M | 900K | 700K | 11.6M | 400K | 300K | 200K | 5.8M | n/a | n/a | n/a |
| Research and Development Revenue Growth | n/a | -100.00% | +6.35% | -4.55% | 0.00% | -2.94% | +1.49% | -9.46% | +15.62% | +68.42% | -7.32% | -36.92% | -2.99% | +1.52% | -34.65% | -53.24% | +248.39% | +3.33% | +7.14% | -77.60% | +410.20% | +8.89% | +9.76% | -86.60% | n/a | -100.00% | +16.00% | -87.05% | +1508.33% | +33.33% | +28.57% | -93.97% | +2800.00% | +33.33% | +50.00% | -96.55% | n/a | n/a | n/a | n/a |